Janczak Dariusz, Ruciński Artur, Rucińska Zuzanna, Janczak Dawid, Dorobisz Karolina, Chabowski Mariusz
Zakład Specjalności Zabiegowych, Katedra Pielęgniarstwa Klinicznego Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu, Wrocław, Polska.
Klinika chirurgiczna 4. Wojskowego Szpitala Klinicznego, Wrocław, Polska.
Polim Med. 2013 Oct-Dec;43(4):221-5.
The authors present the impact of the topical hemostatic agents (PerClot®, Fibrillar®, and Surgiflo®) in both primary arterial anastomoses, and anastomoses with synthetic prostheses.
In 2012, in the Department of Vascular Surgery in Wroclaw, the topical hemostatic dressings were successfully applied to 106 patients (Fibrillar® - 65, PerClot® - 26, and Surgiflo® - 15) in case of difficulties to stop bleeding.
The topical hemostatic agents appear both to reduce blood loss and to shorten the operation time in 95% of cases.
The decrease both in blood loss and operation time can lead to the patient safety improvement.
作者介绍了局部止血剂（PerClot®、Fibrillar®和Surgiflo®）在原发性动脉吻合以及与人工合成假体吻合中的作用。
2012年，在弗罗茨瓦夫血管外科，局部止血敷料成功应用于106例患者（Fibrillar® - 65例、PerClot® - 26例、Surgiflo® - 15例），用于止血困难的情况。
在95%的病例中，局部止血剂似乎既能减少失血，又能缩短手术时间。
失血和手术时间的减少可提高患者的安全性。
